Industry News
Performing And Teaching Breast Examinations For Early Breast Cancer Detection
Nov 20, 2011
MammaCare, a revolutionary tool that has set standards for teaching women and clinicians how to perform clinical breast exams, is training professionals around the country to detect lumps earlier and save lives. Widely-publicized statistics inform women about the importance of early detection of cancer... Read More
A New Pioneer Factor Identified Underlying Progression In Breast Cancer
Nov 20, 2011
The presence of a new pioneer factor, known as PBX1, can guide the response to estrogen in breast cancer cells according to researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center in results published in the open-access journal PLoS Genetics... Read More
Global Prevalence Study Of Infections In Urology And The ESIU-EAU Prostate Biopsy Side Study Run Until The End Of November
Nov 19, 2011
Qualified urologists and urology departments collaborating with microbiologists and infectious disease specialists are encouraged to join the new Global Prevalence Study of Infections in Urology (GPIU) with the last five calendared dates taking place this week and by the end of this month... Read More
Merrimack Pharmaceuticals Initiates Enrollment In Phase 2 Study Of MM-121 In Combination With Erlotinib In Three Groups Of Patients With Lung Cancer
Nov 19, 2011
Merrimack Pharmaceuticals, Inc. announced that the first patient has been dosed in a Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, in combination with erlotinib (Tarceva®), a small molecule directed at the epidermal growth factor receptor (EGFR), in three groups of patients with metastatic non-small cell lung cancer (NSCLC)... Read More
Old Drugs Find New Target For Treating Brain Tumor
Nov 19, 2011
Scientists at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center, in collaboration with colleagues in Boston and South Korea, say they have identified a novel gene mutation that causes at least one form of glioblastoma (GBM), the most common type of malignant brain tumor... Read More
Omega-3 Supplementation May Reduce Joint And Cognitive Side Effects Of Breast Cancer Treatments
Nov 19, 2011
"I know I need this medicine to help lower my chance of cancer recurrence, but it makes my joints ache and stiff. It makes me feel old and I am not sure I can take this medication much longer... Read More
Avastin Approval For Breast Cancer Removed, FDA
Nov 19, 2011
Avastin's approval for the treatment of breast cancer has been revoked, the FDA (Food and Drug Administration) announced today. The US regulatory agency says that Avastin is neither effective nor safe for that particular type of cancer... Read More
Researchers Discover New Way To Form Extracellular Vesicles
Nov 18, 2011
Researchers at NYU Langone Medical Center have discovered a protein called TAT-5 that affects the production of extracellular vesicles, small sacs of membrane released from the surface of cells, capable of sending signals to other cells. When released extracellular vesicles can affect tumor spread, blood clotting and inflammation... Read More
Molecules On Branched-Polymer Surfaces Can Capture Rare Tumor Cells In Blood
Nov 18, 2011
The removal of rare tumor cells circulating in the blood might be possible with the use of biomolecules bound to dendrimers, highly branched synthetic polymers, which could efficiently sift and capture the diseased cells, according to new research at the University of Illinois at Chicago... Read More
Malaria Drug Studied For Treatment Of Metastatic Breast Cancer
Nov 18, 2011
An anti-malaria drug used for more than 60 years is now being studied for use in breast cancer patients whose disease has not responded to traditional chemotherapy treatment. Dr... Read More
Previous Page Next Page